Marta Nevalainen

USPTO Granted Patents = 14 (Patent Applications = 9)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 8.6

ph-index = 4

Forward Citations = 148(Granted Patents)

Location History:

Quincy, MA (US) (2007 - 2013)
Holliston, MA (US) (2021)
Weymouth, MA (US) (2013 - 2024)

Company Filing History:

6 out of 108

Infinity Pharmaceuticals, Inc.

patents

4 out of 12

Infinity Discovery, Inc.

Eisai R&d Management Co., Ltd.

patents

Years Active: 2007-2025

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12391697 - Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase (2025-08-19),

2. 12240838 - Inhibiting agents for Bruton's tyrosine kinase (2025-03-04),

3. 11926619 - Certain pladienolide compounds and methods of use (2024-03-12),

4. 10899753 - Inhibiting agents for Bruton's tyrosine kinase (2021-01-26),

5. 9346769 - Tetrazolones as inhibitors of fatty acid synthase (2016-05-24),

6. 8609706 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners (2013-12-17),

7. 8546432 - Tetrazolones as inhibitors of fatty acid synthase (2013-10-01),

8. 8450350 - Triazoles as inhibitors of fatty acid synthase (2013-05-28),

9. 8236956 - Cyclopamine analogues and methods of use thereof (2012-08-07),

10. 8178690 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners (2012-05-15),

11. 7928244 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners (2011-04-19),

12. 7875628 - Cyclopamine analogues and methods of use thereof (2011-01-25),

13. 7407967 - Cyclopamine analogues and methods of use thereof (2008-08-05),

14. 7230004 - Cyclopamine analogues and methods of use thereof (2007-06-12),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide detailed information on inventor Marta Nevalainen's impressive journey in the world of inventions. Let's delve into her story:

Title:

Trailblazing Inventor Marta Nevalainen: Inspiring Innovations in Cancer Treatment

Introduction:

Marta Nevalainen, a visionary inventor based in Weymouth, MA, is renowned for her unwavering passion for innovation and her commitment to driving positive change through her groundbreaking inventions. With a focus on revolutionizing cancer treatment, Nevalainen has established herself as a trailblazer in the field of medical advancements.

Latest Patents:

Nevalainen holds a significant patent titled "Certain pladienolide compounds and methods of use," which introduces novel pladienolide compounds with potential applications in cancer therapy. These compounds offer promising avenues for targeting spliceosome mutations in cancer treatment, paving the way for more effective therapeutic interventions.

Career Highlights:

Currently affiliated with Eisai R&D Management Co., Ltd., Nevalainen's remarkable career is marked by a dedication to pushing the boundaries of scientific research and translating innovative ideas into tangible solutions. Her relentless pursuit of excellence has led to substantial contributions in the quest for improved cancer therapies.

Collaborations:

Throughout her career, Nevalainen has collaborated with esteemed colleagues such as Gregg F. Keaney and John Wang. These collaborations have been instrumental in fostering a dynamic exchange of ideas and spurring the development of cutting-edge technologies in the field of oncology.

Conclusion:

In conclusion, Marta Nevalainen's remarkable journey as an inventor underscores her commitment to innovation and her profound impact on the landscape of cancer treatment. By inspiring future generations of inventors to think creatively and ambitiously, Nevalainen continues to shape a better tomorrow through her pioneering work in the realm of medical advancements.

This text is generated by artificial intelligence and may not be accurate.